[HTML][HTML] Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices …
JW Gargano - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
JW Gargano
MMWR. Morbidity and mortality weekly report, 2021•cdc.govUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients:
Update from the Advisory Committee on Immunization Practices — United States, June 2021 |
MMWR Skip directly to site content Skip directly to page options Skip directly to AZ link Centers
for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
Search Submit Morbidity and Mortality Weekly Report (MMWR) Section Navigation CDC
Home Facebook Twitter LinkedIn Syndicate Use of mRNA COVID-19 Vaccine After Reports of …
Update from the Advisory Committee on Immunization Practices — United States, June 2021 |
MMWR Skip directly to site content Skip directly to page options Skip directly to AZ link Centers
for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
Search Submit Morbidity and Mortality Weekly Report (MMWR) Section Navigation CDC
Home Facebook Twitter LinkedIn Syndicate Use of mRNA COVID-19 Vaccine After Reports of …
On June 23, 2021, the Advisory Committee on Immunization Practices concluded that the benefits of COVID-19 vaccination to individual persons and at the population level clearly outweighed the risks of myocarditis after vaccination.
cdc.gov